Table 1.

CPMI-Derived Performance Metrics and Data Points Used in GHATI

Elements	Description
E1	Reason for delay at facility
E2	Transportation time
E3	Mean and median time: first medical contact to ECG
E4	Mean and median time: arrival to ECG
E5	Mean and median time: arrival to cath lab
E6	Mean and median time: arrival to fibrinolytic therapy
E7	Mean and median time: arrival to device time
E8	Proportion of patients with LVEF <40%
E9	Proportion of patients discharged alive
E11	Proportion of patients receiving P2Y12 inhibitor between first medical contact and catheterization
E12	Proportion of patients received at facility in cardiogenic shock
E13	Patients who experienced cardiac arrest before intervention
E14	Patients who experienced cardiac arrest after intervention
E15	Patients who are current smokers
E16	Patients who are female
Performance metrics	Description
PM1	Aspirin upon arrival
PM2	Aspirin prescribed at discharge
PM3	Beta-blocker at discharge
PM4	Statin at discharge
PM5	Evaluation of LVEF
PM6	ACE-I or ARB for LVSD (LVEF <40%) at discharge
PM7	Door-to-needle time (fibrinolytic therapy)
PM8	STEMI patients receiving primary PCI within 90 min
PM9	Reperfusion therapy
PM13	P2Y12 inhibitor at discharge

ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; GHATI = Global Heart Attack Treatment Initiative; LVEF = left ventricular ejection fraction; LVSD = left ventricular systolic dysfunction; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction.